Emerging role of epigenetic therapies in cutaneous T-cell lymphomas. - Wikidata - wikimedia - TriplyDB

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

http://www.wikidata.org/entity/Q37810272

about

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells Regulation of germinal center, B-cell memory, and plasma cell formation by histone modifiers Interpreting clinical assays for histone deacetylase inhibitors.Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.Targeted therapies for cutaneous T-cell lymphomas.Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases.The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma.Histone Deacetylase Inhibitors: Synthesis of Cyclic Tetrapeptides and their Triazole Analogues Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives.

P2860

Q24200183-9FCCE979-5A2A-4E4F-B9C9-F494E54336D1 Q24203887-9024015C-C5D7-4BFC-816A-2CAFA36BE77D Q28257534-513C1FE5-912B-4882-9001-9D214E195232 Q34541050-F0421660-E9E4-4893-BFE8-69283A505530 Q35003657-011F6E21-142A-4638-9C59-93824BACB271 Q35640652-6196DFA0-DF1E-4648-8FC9-D395F81A2ADB Q38229634-D32BCD25-9907-4403-B718-1720EA551926 Q38973120-BCF96756-ECE9-456F-B6BD-76A383D6405C Q40715942-A3CA6C37-F889-446F-AFDD-AFD4E19736A4 Q41923633-298378F6-D6B8-4AA4-84FD-C0A9561AEF80 Q47133466-B5DB62B0-029A-4B3D-9A45-295B2CAD195C

P2860

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

http://www.wikidata.org/entity/Q37810272

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@en

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@nl

type

label

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@en

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@nl

prefLabel

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@en

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

@nl

P1433

Q37810272-56E18C10-3D98-4742-8961-890C2A34FCC0

P1476

Q37810272-FF6B5B86-698F-4043-A210-667D517676DF

P2093

Q37810272-9D61B504-3DA5-474F-96D6-8FB1DB2EE882

Q37810272-F69964D5-0000-4882-88D4-4D50A9661174

P2860

Q37810272-01B98745-9E13-4B74-A27A-681646AF8FC1

Q37810272-01ED33D1-0415-48CC-9495-40D1BB3DD121

Q37810272-068EC65A-24B0-4B4D-BC3C-C8A6416E9076

Q37810272-08F5512A-0A9B-4D85-8F94-E1BFB1FEB0B4

Q37810272-0B3D1199-E5EB-4C29-B6FA-0A1EE3D989F9

Q37810272-0C04B794-B7AC-4941-AB0A-DE61A0DA4CB2

Q37810272-0C1BA484-E910-4E1D-B6C9-3CD8E199E0C0

Q37810272-0E8233C0-E21F-440E-87F9-DA62522F4BEE

Q37810272-0F330B8E-A5E0-4F4B-8B86-1DF661351B83

Q37810272-1025ED5B-EBAF-491B-B3AF-C8FF51C4C0D0

P304

Q37810272-C67552BB-4213-4F28-B096-352AA0A721FF

P31

Q37810272-DEB0CAE8-CD4C-4732-ABB8-5375F0503517

P356

Q37810272-D0310B8C-6F00-4A3E-922F-B85CA3EB4B08

P433

Q37810272-700A908A-F7E0-4B93-9370-0D03C586C910

P478

Q37810272-DAD3108C-AC34-4140-8ECD-15AD1FF95269

P50

Q37810272-277F4DA4-F018-4C1D-952E-C0EDA72C2FB3

P577

Q37810272-20B1A52C-C321-4D86-9297-A807113D7115

P698

Q37810272-7D0850A8-EB33-4A28-8E5C-BB7D41DF3C10

P356

P1433

Expert Review of Hematology

P1476

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas

@en

P2093

Jasmine Zain

http://www.w3.org/2001/XMLSchema#string

Owen A O'Connor

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity

DNA methylation patterns and epigenetic memory

Translating the Histone Code

DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

Negative control of p53 by Sir2alpha promotes cell survival under stress

Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

P304

187-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EHM.10.9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

David Kaminetzky

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21083462

http://www.w3.org/2001/XMLSchema#string